In short, he Canadian government not only sold off commercial rights to its Ebola vaccine to a for-profit firm at sale-price rates. It also paid the lion’s share of costs required to test the vaccine for human use.
Ebola Outbreak - 0 views
-
Nice clearinghouse for Ebola news
The strange tale of Canada's ebola vaccine: Walkom | Toronto Star - 0 views
-
This article tells the fascinating (and somewhat mysterious) story behind the licensing of the Canadian Ebola vaccine, one of two vaccines fast-tracked for clinical trials. I recommend this read to anyone interested in biotech and intellectual property.
Dr. Matthew's Passion - New York Times - 0 views
A Bad Flu Season Hits the Halfway Mark, C.D.C. Says - NYTimes.com - 0 views
-
He said doctors did not recommend the antivirals often enough, and should prescribe them even before an office visit for patients with flu symptoms and a high risk of complications.
« First
‹ Previous
101 - 120
Next ›
Last »
Showing 20▼ items per page
